Using integrated approaches to develop therapies for healthy aging
Integrative Omics to enhance therapeutics development for healthy aging
This study is looking for ways to help people age healthier by finding signs in our bodies that are linked to living longer, and it's for anyone interested in how we can prevent diseases as we get older.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Translational Genomics Research Inst NIH-funded |
| Lab location | 1 site (Phoenix, United States) |
| Project ID | NIH-10693877 on NIH RePORTER |
What this research studies
This research investigates how to enhance therapeutic development aimed at promoting healthy aging by identifying biological markers associated with longevity. It employs a combination of human longitudinal studies and cross-species analyses to discover metabolites and proteins that contribute to slow aging and the prevention of age-related diseases. By integrating data from various sources, the research aims to uncover common pathways that could lead to effective interventions for extending human lifespan and improving health in older adults.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults interested in interventions that promote healthy aging and longevity.
Not a fit: Patients with acute age-related diseases or those who are not yet experiencing age-related health issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve health and longevity in aging populations.
How similar studies have performed: Previous research has shown promise in using integrated approaches to understand aging and develop longevity-enhancing therapies, indicating a potential for success in this area.
Where this research is happening
Phoenix, United States
- Translational Genomics Research Inst — Phoenix, United States (Active)
Researchers
- Principal investigator: Schork, Nicholas Joseph — Translational Genomics Research Inst
- Study coordinator: Schork, Nicholas Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.